quired for the suppression of alpha-synuclein neurotoxicity. Neuron
53:519 –533.
Ikeuchi T, Kakita A, Shiga A, Kasuga K, Kaneko H, Tan CF, Idezuka J,
Wakabayashi K, Onodera O, Iwatsubo T, Nishizawa M, Takahashi H,
Ishikawa A (2008) Patients homozygous and heterozygous for SNCA
duplication in a family with parkinsonism and dementia. Arch Neurol
65:514 –519.
Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc
1:2406 –2415.
Kahle PJ, Neumann M, Ozmen L, Muller V, Jacobsen H, Spooren W, Fuss B,
Mallon B, Macklin WB, Fujiwara H, Hasegawa M, Iwatsubo T,
Kretzschmar HA, Haass C (2002) Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep
3:583–588.
Kamp F, Beyer K (2006) Binding of alpha-synuclein affects the lipid packing
in bilayers of small vesicles. J Biol Chem 281:9251–9259.
Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic -synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy
bodies. J Neurosci 27:1405–1410.
Krueger SR, Kolar A, Fitzsimonds RM (2003) The presynaptic release apparatus is functional in the absence of dendritic contact and highly mobile
within isolated axons. Neuron 40:945–957.
Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, Kato T, Mitani S,
Iwatsubo T (2008) A systematic RNAi screen reveals involvement of en- docytic pathway in neuronal dysfunction in alpha-synuclein transgenic C.
elegans. Hum Mol Genet 17:2997–3009.
Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle
M, Nemani V, Chaudhry FA, Edwards RH, Stefanis L, Sulzer D (2006)
-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci
26:11915–11922.
McKeith IG, Mosimann UP (2004) Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 10 [Suppl 1]:S15–S18.
McLean PJ, Kawamata H, Hyman BT (2001) Alpha-synuclein-enhanced
green fluorescent protein fusion proteins form proteasome sensitive in- clusions in primary neurons. Neuroscience 104:901–912.
Morfini G, Pigino G, Opalach K, Serulle Y, Moreira JE, Sugimori M, Llina ́ s
RR, Brady ST (2007) 1-Methyl-4-phenylpyridinium affects fast axonal
transport by activation of caspase and protein kinase C. Proc Natl Acad
Sci U S A 104:2442–2447.
Mukaetova-Ladinska EB, McKeith IG (2006) Pathophysiology of synuclein
aggregation in Lewy body disease. Mech Ageing Dev 127:188 –202.
Nakamura K, Nemani VM, Wallender EK, Kaehlcke K, Ott M, Edwards RH
(2008) Optical reporters for the conformation of -synuclein reveal a
specific interaction with mitochondria. J Neurosci 28:12305–12317.
Neale EA, Bowers LM, Jia M, Bateman KE, Williamson LC (1999) Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis
at the nerve terminal. J Cell Biol 147:1249 –1260.
Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA,
Nicoll RA, Edwards RH (2010) Increased expression of alpha-synuclein
reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65:66 –79.
Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Mu ̈ ller
V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ,
Kretzschmar HA, Haass C (2002) Misfolded proteinase K-resistant hy- perphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest
110:1429 –1439.
Nonet ML, Saifee O, Zhao H, Rand JB, Wei L (1998) Synaptic transmission
deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci
18:70 – 80.
Nonet ML, Holgado AM, Brewer F, Serpe CJ, Norbeck BA, Holleran J, Wei L,
Hartwieg E, Jorgensen EM, Alfonso A (1999) UNC-11, a Caenorhabditis
elegans AP180 homologue, regulates the size and protein composition of
synaptic vesicles. Mol Biol Cell 10:2343–2360.
